Tuberculosis treatment may be shortened

September 2, 2009

According to Dutch researcher Hanneke Later-Nijland, it may be possible to shorten the duration of treatment for tuberculosis. Due to the long duration of treatment, not every patient sees it through. Partly because of this, tuberculosis is one of the most lethal diseases in developing countries.

The research conducted by Hanneke Later-Nijland is helping to shorten the duration of treatment for . Later-Nijland studied different groups of Indonesian tuberculosis patients. She believes it may be possible to shorten the duration of treatment by increasing the dose of the important drug rifampicin. After increasing the dose, the concentration of the drug in the was higher than expected. 

In addition, the tuberculosis patients in Later-Nijland's study did not experience more or different adverse effects at an increased dose than at a standard dose. Therefore increasing the dose of rifampicin might make it possible to reduce the length of treatment for tuberculosis without additional consequences. Research involving larger groups of patients will be needed to confirm this conclusion.

Tuberculosis and diabetes

Later-Nijland also conducted research into the reduced effectiveness of treatment in tuberculosis patients who also have . Her research revealed that the concentration of rifampicin in the blood plasma of patients with type 2 diabetes was lower than in patients with tuberculosis alone but who were administered the same dose. Whether tuberculosis patients with type 2 diabetes would benefit from a higher dose of rifampicin is a subject for further research.

Hanneke Later-Nijland started her research in October 2004 at Radboud University Nijmegen Medical Centre. She carried out her research within the Indonesian, Tanzanian and Dutch research network Poverty Related Infection Oriented Research, or PRIOR. PRIOR focused on research into poverty-related such as tuberculosis, HIV and
malaria, and was funded by NWO.

Source: NWO


print this article email this article download pdf blog this article bookmark this article     Stumble it Digg this share on Facebook retweet share on Reddit add to delicious
Rate this story - not rated yet


September 2, 2009 all stories

Comments: 0

not rated yet
  • Stumble this up

  • Digg this

  • share this

  • hide
  • Related Stories

  • Tuberculosis treatment may be shortened
    created Aug 17, 2009 | popularity not rated yet | comments 0
  • Drug-resistant tuberculosis on the increase in the UK
    created May 02, 2008 | popularity not rated yet | comments 0
  • New tuberculosis vaccine is developed
    created Jun 06, 2007 | popularity not rated yet | comments 0
  • Slow-growing TB bacteria point the way to new drug development
    created Mar 30, 2009 | popularity not rated yet | comments 0
  • Higher drug doses needed to defeat tuberculosis, researchers report
    created Jul 30, 2009 | popularity not rated yet | comments 0



  • hide
  • Relevant PhysicsForums posts

Other News

An end to sleep problems? Researchers discover enzyme behind effects of sleep deprivation

Medicine & Health / Research

created 1hour ago | popularity not rated yet | comments 0

There is hope for those who miss one night too many or whose children keep them up at night. The unwelcome effects of a bad night's sleep - forgetfulness, impaired mental performance - can be dealt with by reducing the concentration ...


Ginkgo biloba doesn’t prevent cardiovascular events but may have potential peripheral artery disease benefits

Medicine & Health / Research

created 1hour ago | popularity not rated yet | comments 0

(PhysOrg.com) -- Ginkgo biloba didn’t prevent cardiovascular death or major events such as heart attack and stroke in people age 75 and older, but the herb may affect peripheral vascular disease, according to research reported ...


Implant-based cancer vaccine is first to eliminate tumors in mice

Implant-based cancer vaccine is first to eliminate tumors in mice

Medicine & Health / Cancer

created 19 hours ago | popularity 4.7 / 5 (22) | comments 4

(PhysOrg.com) -- A cancer vaccine carried into the body on a carefully engineered, fingernail-sized implant is the first to successfully eliminate tumors in mammals, scientists report this week in the journal ...


Brain's endocannabinoid signaling pathway kept in check by two enzymes

Medicine & Health / Research

created 17 hours ago | popularity 4 / 5 (4) | comments 1

(PhysOrg.com) -- A research team has shown that blocking the degradation of two naturally occurring cannabinoids in the endocannabinoid signaling pathway of the brain produces marijuana-like behavioral effects in mice, according ...


Study sheds light on brain's fear processing center

Medicine & Health / Research

created 21 hours ago | popularity 5 / 5 (3) | comments 1

Breathing carbon dioxide can trigger panic attacks, but the biological reason for this effect has not been understood. A new study by University of Iowa researchers shows that carbon dioxide increases brain acidity, which ...